H5N1 avian influenza subunit vaccines (Crossbeta Biosciences BV)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameH5N1 avian influenza subunit vaccines (Crossbeta Biosciences BV)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrossbeta Biosciences BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrossbeta Biosciences BV
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A